Ric Arseneau, M.D., FRCP(C), MA(Ed), MBA, FACP, CGP, is an academic general internist working out of St. Paul’s Hospital and BC Women’s Hospital and is an Associate Clinical Professor at the University of British Columbia, all in Vancouver, British Columbia, Canada. He serves as the Director of Program Planning and a Clinician at the BC Women’s Hospital Complex Chronic Diseases Program (CCDP), a program for patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Fibromyalgia and symptoms attributed to Chronic Lyme Disease.
Dr. Arseneau’s clinical interests include chronic fatigue syndrome, fibromyalgia, and eating disorders.
Notable studies[edit | edit source]
Clinic location[edit | edit source]
Talks and interviews[edit | edit source]
- 3-5 May 2018, ME/CFS Canadian Collaborative Team Conference - Speech title: ME/CFS: Central Sensitivity Syndromes and the Complex Chronic Diseases Program at BC Women’s Hospital
- Jun 2018, ME/CFS, FM, and Related Disorders for BC Women's Hospital Chronic Complex Disease Program Part 1, Part 2
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- "ME/CFS Canadian Collaborative Team Conference program" (PDF). Retrieved Mar 6, 2019.
chronic disease - a disease or condition that usually lasts for 3 months or longer and may get worse over time
Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.